(lp0
S'Albany Molecular Research, Inc.  Ducks Under The Trend Line Midway Monitor - 8 hours ago Albany Molecular Research, Inc.  shares have experienced a recent steady downtrend, causing some concern for shareholders.Albany Molecular Research, Inc.  Accounts Payable At $111.147 ... - RealistInvestor.comAlbany Molecular Research, Inc.  Quarterly Deferred Revenue At ... - Enterprise Leader'
p1
aS'BRIEF-Albany Molecular Research enters into agreement with pharmaceutical ... Reuters - Feb 21, 2017 Albany Molecular Research Inc - entered into an agreement with pharmaceutical group Ferrer and Accord Healthcare, Inc. * Albany Molecular - agreement to develop, manufacture undisclosed complex parenteral drug product for registration, subsequent&nbsp;...'
p2
aS'Albany Molecular Research, Inc. : Analysts bet a 43.5 percent change in ... Post Analyst - 18 hours ago Albany Molecular Research, Inc.  traded at an unexpectedly low level on 03/21/2017 when the stock experienced a -4.54 loss to a closing price of $13.24.'
p3
aS'AMRI to Present at Barclays Global Healthcare Conference PR Newswire  - Feb 23, 2017 ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc.  announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 16&nbsp;...'
p4
aS"Moody's affirms Albany Molecular's B3 CFR following announced acquisition of ... Moodys.com   - May 9, 2016 New York, May 09, 2016 -- Moody's Investors Service  today affirmed Albany Molecular Research Inc.'s  ratings, including its B3 Corporate Family Rating , B3-PD Probability of Default Rating  and the B1 rating on the company's&nbsp;..."
p5
aS'An Inside Look at Trading Hot Stocks: Albany Molecular Research, Inc. (AMRI ... Post Analyst - Mar 21, 2017 Albany Molecular Research, Inc. has a consensus outperform rating from 3 Wall Street analysts, and the number of shares currently sold short amount to at least 21.05% of shares outstanding.Stock Returns: Albany Molecular Research Inc  versus Pacific ... - CML NewsStock inside Traders Spotlight: Albany Molecular Research, Inc.  - Is stories'
p6
aS"Albany Molecular Research, Regeneron Pharmaceuticals upbeat Albany Times Union - Aug 4, 2016 Two of the region's biopharmaceutical companies released second-quarter results on Thursday, giving investors and analysts insight into their strengths and goals midway through the fiscal year."
p7
aS'Albany Molecular Research Inc.  Plunges 5.67% on February 22 Equities.com - Feb 22, 2017 Albany Molecular Research Inc.  had a rough trading day for Wednesday February 22 as shares tumbled 5.67%, or a loss of $-0.93 per share, to close at $15.46.Albany Molecular Research, Inc.  Signs Deal With Accord ... - FinancialsTrend'
p8
aS'Albany Molecular Research enters partnership in marijuana-related therapy studies Albany Times Union - Jun 24, 2016 With a new partnership, Albany Molecular Research, Inc. aims to advance an evolving area in therapeutics - cannabinoids.'
p9
aS'Albany Molecular Research Inc.  Moves Higher on Volume Spike for March 10 Equities.com - Mar 10, 2017 Albany Molecular Research Inc.  traded on unusually high volume on Mar. 10, as the stock gained 2.63% to close at $13.65.Healthcare Oversold Stocks: Genesis Healthcare, Inc. , Albany ... - Benchmark Monitor'
p10
a.